Results
1 -
10 of
62
(Click
here to explore results)
Neglected Diseases and Drug Discovery, Chapter 6 Drugs for Kinetoplastid Diseases – Current Situation and Challenges . Simon L. Croft
, 2012
, Pages 134-158
Carbohydrates in Drug Design and Discovery, Chapter 11 Amphiphilic Aminoglycoside Antimicrobials in Antibacterial Discovery . Bala Kishan Gorityala, Goutam Guchhait, Frank Schweizer
, 2015
, Pages 255-285
The Dictionary of Substances and their Effects (DOSE): T-Z and Index (2), Index of chemical names and synonyms . Sharat Gangolli
, 1999
, Volume 7
, Pages 715-914
The Dictionary of Substances and their Effects (DOSE): K-N (2), K-N compounds . S. Gangoli
, 1999
, Volume 5
, Pages 1-954
Handbook of Culture Media for Food and Water Microbiology (3), Chapter 10 Culture Media for the Detection and Enumeration of Bifidobacteria in Food Production . Eoin Barrett, Paola Mattarelli, Paul J. Simpson, Paul W. O’Toole, Gerald F. Fitzgerald, R. Paul Ross, Catherine Stanton
, 2012
, Pages 199-227
Drug Discovery for Leishmaniasis, I. Appraisal of Leishmaniasis Chemotherapy, Current Status and Pipeline StrategiesChapter 1 Leishmaniasis, Impact and Therapeutic Needs . Jorge Alvar, Byron Arana
, 2018
, Pages 1-23
Drug Discovery for Leishmaniasis, Chapter 18 Molecular Basis of Drug Resistance in Leishmania . Annelies Mondelaers, Sarah Hendrickx, Guy Caljon, Louis Maes
, 2018
, Pages 371-386
Toxicological Effects of Veterinary Medicinal Products in Humans: Volume 1, CHAPTER 8 Antimicrobial Drugs . K. N. Woodward
, 2013
, Volume 1
, Pages 273-380
Carbohydrate Chemistry: Volume 15 Part I, Antibiotics . N. R. Williams
, 1983
, Volume 15
, Pages 176-197
Drug Discovery for Leishmaniasis, Chapter 3 From Bench to Bedside: Development and Optimization of Clinical Therapies for Visceral Leishmaniasis . Fabiana Alves, Jean-Yves Gillon, Byron Arana, Thomas P. C. Dorlo
, 2018
, Pages 37-54